Method for preventing cats from shedding Toxoplasma oocysts after infection of such cats
AssigneeKansas University Endowment Association
InventorsJacob K. Frenkel, Donald D. Smith
Life of this patent
Estimating the term…
Loading patent…
AssigneeKansas University Endowment Association
InventorsJacob K. Frenkel, Donald D. Smith
Estimating the term…
A method of preventing, or at least substantially minimizing, shedding of Toxoplasma oocysts by cats is described which can be begun after infection of the cat and may serve to reduce the contamination with infectious oocysts of soils around areas of human habitation. The method involves administration, in effective amounts of a drug agent selected from the group consisting of monensin or salinomycin. The administration is preferably oral, and can be accomplished by mixing the drug with the cat's food or via a slow release dosage form. The drug treatment is normally commenced within about two days after infection, and is continued for a period of at least about two weeks.
A method of preventing or minimizing shedding of Toxoplasma oocysts by a cat after Toxoplasma infection of such cat, comprising the steps of administering to the cat, prior to the onset of oocyst shedding, an effective amount of an agent selected from the group consisting of monensin and salinomycin, and continuing such administration for a period of time thereafter sufficient to maintain said prevention or minimization.
Dependencies are inferred from the claim text.